PPR-118 - Trends in the prescription of central nervous system depressants in patients with Chronic Obstructive Pulmonary Disease in the United Kingdom Primary Care, 2000 – 2022

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-118
• By: OLAOYE, Omotayo (Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada)
• Co-author(s): Ms Omotayo Olaoye (Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada / Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada)
  Ms. Sophie Dell'Aniello (Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada)
  Ms. Sarah Beradid (Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada)
  Dr. Pierre Ernst (Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada / Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada / Department of Medicine, McGill University, Montreal, Canada)
  Prof. Samy Suissa (Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada / Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada / Department of Medicine, McGill University, Montreal, Canada)
  Prof. Christel Renoux (Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada / Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal , Canada / Department of Medicine, McGill University, Montreal, Canada / Department of Neurology and Neurosurgery, McGill University, Montreal, Canada)
  
• Abstract:

  Background
  Prescribing patterns of central nervous system (CNS) depressants have evolved in recent years, but trends in patients with chronic obstructive pulmonary disease (COPD) remain unknown. Assessing these trends is essential given the potential risk of respiratory depression and other adverse respiratory events in this population. Therefore, ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login